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Introduction
AKAP350 (AKAP450/CG-NAP/AKAP9) is a multiple 
spliced A-kinase anchoring protein (AKAP), which assembles 
protein complexes at the Golgi apparatus and the centrosomes.1-3 
Largely known as the main microtubule nucleating organelle, 
centrosomes have garnered interest during the last decade because 
of their central role in various signaling events, including those 
involved in the establishment of cell polarity,4 and the regulation 
of the cell cycle progression.5 In this regard, AKAP350 recruits to 
the pericentriolar matrix several signaling proteins implicated in 
the regulation of these processes, including PKA, Cdk2,6 the Ran 
small GTPase,7 and the γ-TURC associated proteins GCP2/3.8 
Although AKAP350 participation in the establishment of 
cell polarity has been well established,9,10 the relevance of this 
scaffold protein in the regulation of the cell cycle has not been 
characterized to date.
AKAP350 localization at the centrosomes is mediated by 
a carboxyl-terminal 92 aminoacid region (AKAP450 3699–
3790), the PACT domain, which also interacts with calmodulin 
and is highly conserved in functionally related centrosomal 
proteins.11 Previous studies demonstrated that expression of the 
PACT domain induces a decrease in AKAP350 localization at 
the centrosomes, and inhibition of centrosomal duplication.12 
A different study suggested that AKAP350-dependent 
recruitment of cyclin E-Cdk2 to the centrosomes could induce 
centrosomal amplification.6 Even though both studies pointed 
to a facilitative role of AKAP350 in centrosomal duplication, 
their data are not convergent, nor they make focus, on the 
understanding of how AKAP350 participates in the cell cycle 
progression.
Centrosomal duplication is coordinated with DNA 
replication, both events initiated at the G
1
/S transition.13 A key 
enzyme in the coordination of these events is Cdk2. At late G
1
, 
there is an increase in cyclin E levels, which leads to activation 
of Cdk2. The cyclin E–Cdk2 complex phosphorylates specific 
substrates involved in the activation of both DNA synthesis and 
centrosomal duplication.14 Interestingly, the initiation of DNA 
synthesis is dependent, not only on cyclin E–Cdk2 activity, but 
also on the proper location of this complex at the centrosomes.15
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aKaP350 (aKaP450/aKaP9/cG-NaP) is an a-kinase anchoring protein, which recruits multiple signaling proteins to 
the Golgi apparatus and the centrosomes. several proteins recruited to the centrosomes by this scaffold participate 
in the regulation of the cell cycle. Previous studies indicated that aKaP350 participates in centrosome duplication. In 
the present study we specifically assessed the role of aKaP350 in the progression of the cell cycle. Our results showed 
that interference with aKaP350 expression inhibits G1/s transition, decreasing the initiation of both DNa synthesis and 
centrosome duplication. We identified an aKaP350 carboxyl-terminal domain (aKaP350cTD), which contained the 
centrosomal targeting domain of aKaP350 and induced the initiation of DNa synthesis. Nevertheless, aKaP350cTD 
expression did not induce centrosomal duplication. aKaP350cTD partially delocalized endogenous aKaP350 from the 
centrosomes, but increased the centrosomal levels of the cyclin-dependent kinase 2 (cdk2). accordingly, the expression 
of this aKaP350 domain increased the endogenous phosphorylation of nucleophosmin by cdk2, which occurs at the G1/s 
transition and is a marker of the centrosomal activity of the cyclin e-cdk2 complex. cdk2 recruitment to the centrosomes 
is a necessary event for the development of the G1/s transition. altogether, our results indicate that aKaP350 facilitates 
the initiation of DNa synthesis by scaffolding cdk2 to the centrosomes, and enabling its specific activity at this organelle. 
although this mechanism could also be involved in aKaP350-dependent modulation of centrosomal duplication, it is not 
sufficient to account for this process.
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The aim of our work was to analyze AKAP350 participation 
in cell cycle progression by taking advantage of specific loss-of-
function studies in proliferating cells and to obtain insights into 
the mechanisms involved.
Results
AKAP350 participates in G
1
/S transition
In order to evaluate the participation of AKAP350 in cell 
cycle progression, we studied the effect of specifically decreasing 
AKAP350 expression on DNA content in HepG2 cells. Cells were 
transfected with a non-specific (control) and two AKAP350-
specific (AKAP350KD) siRNAs. We found that the decrease in 
AKAP350 expression induced a 40% increase in the population 
of 2N-containing cells (Fig. 1A). To discriminate if this increased 
population corresponded to cells in G
0
 (quiescent) or G
1
 phase, 
we analyzed cyclin D1 levels. AKAP350KD cells showed a 
significant increase in cyclin D1 (Fig. 1B), thus indicating that 
the accumulation of 2N-containing cells was due to an increase 
in cells that had entered the cell cycle. We further characterized 
AKAP350KD cells regarding their viability. We did not find any 
change in the total number of viable cells, as measured by MTT 
assay, or in the number of dead cells, assessed by propidium 
iodide incorporation of non-fixed cells (data not shown), but 
we detected an increase in early apoptosis in AKAP350KD cells 
(Fig. 1C). Altogether, our results indicate that the decrease in 
AKAP350 expression inhibits G
1
/S transition, inducing G
1
 arrest.
AKAP350CTD induces the initiation of DNA synthesis
AKAP350 recruits to the centrosomes several proteins 
involved in G
1
/S transition, including PKA and Cdk2. To 
investigate the mechanism involved in AKAP350 participation 
in G
1
/S transition, we prepared stable cell lines expressing the 
AKAP350(3330–3595) domain, equivalent to AKAP450(3643–
3908), fused to GFP (AKAP350CTD) or GFP (control). 
AKAP350CTD harbors the centrosomal targeting domain 
of AKAP350, the PACT domain, and the 50 amino acids 
located upstream the PACT domain. We first characterized two 
different clones (AKAP350CTD 1 and 4) for the localization 
of the fusion protein, and that of the endogenous AKAP350. 
Our results showed that AKAP350CTD localized exclusively 
at the centrosomes in both clones (Fig. 2A), inducing a partial 
displacement of the endogenous AKAP350 (Fig. 2B).
We analyzed the effect of AKAP350CTD expression on the 
DNA content of HepG2 cells. The expression of this AKAP350 
domain induced a decrease in the population of 2N-containing 
cells, with a concomitant increase in 2n < x < 4N cells, both 
Figure 1. effect of aKaP350 knock down on the cell cycle. hepG2 cells were transfected with siRNa1 or siRNa2 (aKaP350KD), specifically targeted to 
aKaP350 mRNa, or with a scrambled control (control), and allowed to grow for 48 h. (A) control and siRNa1 transfected cells were fixed with cold 70% 
ethanol, marked with propidium iodide and analyzed by flow cytometry. The figure shows typical outputs of the cell population distribution of control 
and aKaP350 KD cells (left) and the histogram representing the percentage of cells in the different phases of the cell cycle. similar results were obtained 
with siRNa2 transfected cells. (B) aKaP350 and cyclin D1 expression were analyzed by western blot in control and siRNa1 transfected cells. α-Tubulin 
was used as loading control. These results were confirmed in siRNa2 transfected cells. (C) control and aKaP350KD hepG2 cells were stained with 
annexin V-FITc and propidium iodide (PI) and the percentages of apoptotic (annexin+) and dead (PI+) cells were determined by flow cytometry analysis. 
Bars represent the percentages of cells undergoing early apoptosis (annexin+/PI-). Results are means ± s.e.m. of four (A and B) or three (C) independent 
experiments. *P < 0.05
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in AKAP350CTD1 and AKAP350CTD4 
cell lines (Fig. 3A). These results indicated 
an increase in the S phase population and a 
decrement of G
0
/G
1
 cells. In agreement with 
these results, we found that AKAP350CTD 
cells expressed higher levels of cyclin A 
(+130%, P < 0.01) (Fig. 3B). These findings 
indicated that AKAP350CTD expression 
activated the G
1
/S transition. We studied if 
this effect was accompanied by changes in 
cell proliferation. Our results showed that 
AKAP350CTD expressing clones did not 
differ in the total number of viable or dead 
cells (Fig. 3C and D), which indicated that 
AKAP350CTD expression did not affect cell 
proliferation or death in these conditions.
AKAP350 participates in centrosomal 
duplication
Previous studies indicated that the 
expression of AKAP450(3699–3796) inhibited 
the initiation of centrosomal duplication,12 
while expression of AKAP450(2895–3908) led 
to centrosomal amplification.6 We analyzed 
the effect of the specific decrease in AKAP350 
expression on the number of centrosomes 
per cell (Fig. 4A). Our results showed 
that AKAP350KD cells have an increased 
population of cells with one centrosome with 
a concomitant decrease in cells with two 
centrosomes, which indicates that the loss of 
AKAP350 expression leads to the inhibition of 
centrosomal duplication. Considering that the 
initiation of DNA synthesis was also inhibited 
in AKAP350KD cells, and that AKAP350CTD expression was 
enough to promote this process, we further studied the effect 
of AKAP350CTD expression on centrosomal duplication. We 
analyzed the number of centrosomes per cell, and their extent 
of separation in AKAP350CTD cells. We discriminated cells 
containing one centrosome from those containing two attached 
and two separated centrosomes, which would correspond to cells 
in G
0
/G
1
, S, and G
2
/mitosis phases, respectively. No significant 
difference in the number of cells from each population was 
observed (Fig. 4B). We also did not observe centrosomal 
amplification in AKAP350CTD cells. Thus, the expression 
of AKAP350CTD was capable of inducing the initiation of 
DNA synthesis, but not centrosomal duplication. These results 
indicated that, while AKAP350 participation in DNA synthesis 
lies in its carboxyl-terminal domain, there are other fragments 
of the molecule involved in the modulation of centrosomal 
duplication.
AKAP350CTD increases centrosomal Cdk2 activity
Among the proteins involved in G
1
/S transition and centrosomal 
duplication, Cdk2 interacts with AKAP45O(2895–3908),6 while 
PKA has two different interaction motifs located at positions 
1439–1456 and 2551–2565 of the AKAP450 sequence,1-3 which 
are excluded from AKAP350CTD. Immunofluorescence 
analysis indicated that Cdk2 localizes at the centrosomes both in 
control and AKAP350CTD cells (Fig. 5A), but was not suitable 
for quantitative analysis (see Materials and Methods). Therefore, 
we investigated if AKAP350CTD affected the centrosomal 
localization of Cdk2 by analyzing Cdk2 expression in centrosome-
enriched subcellular fractions. We found that AKAP350CTD 
expression did not induce any change in total Cdk2 expression, 
but increased centrosomal Cdk2 levels (Fig. 5B). We further 
studied AKAP350CTD effects on centrosomal activity of Cdk2 
by determining the phosphorylation status of its centrosomal 
substrate nucleophosmin (NPM). NPM is a well-characterized 
centrosomal target of cyclin E-Cdk2, whose phosphorylation 
promotes the initiation of centrosomal duplication.16 We analyzed 
NPM phosphorylation at its specific Cdk2 site, and found that 
the expression of AKAP350CTD induced an increase in NPM 
phosphorylation by Cdk2 (Fig. 6).
Discussion
Previous studies demonstrated the participation of AKAP350 
in centrosomal duplication.6,12 The first of these studies showed 
that the expression of the PACT domain induced abrogation of 
cell cycle progression either in G
2
 phase or in G
1
 phase, in HeLa 
Figure 2. characterization of aKaP350cTD cells. aKaP350cTD1 and aKaP350cTD4 cells were 
cultured for 24 h, fixed with methanol and stained for γ-tubulin (A) or fixed with paraformal-
dehyde and stained for aKaP350 (B). Immunofluorescence images were obtained by confocal 
microscopy. (A) Images show γ-tubulin staining and aKaP350cTD-GFP fluorescence. arrows 
indicate the centrosomes with orthogonal view. (B) Images show the z-projection of aKaP350 
staining. arrows indicate centrosomal localization of aKaP350. Bars represent the mean ± 
s.e.m. of the % of aKaP350 fluorescence intensity associated with centrosomes for three inde-
pendent experiments. Bar: 5 μm.
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or RPE1 cells, respectively.12 On the other hand, the second study 
found that the expression of AKAP45O(2895–3908) did not 
induced any change in the cell cycle distribution of CHO cells.6 
The differences between these studies may lay in two different 
facts: First, the AKAP350 domains used affect differentially the 
localization of the endogenous protein. Second, both constructs 
interact with different cell cycle proteins.6,11,12 Therefore, although 
these studies supported the concept that AKAP350 participates 
in the modulation of cell cycle progression, it was not clear which 
effects were secondary to endogenous AKAP350 delocalization, 
and which to the presence of its derived fusion protein at the 
centrosomes.
We first studied the effect of specifically decreasing AKAP350 
expression by RNA interference on the cell cycle distribution 
of HepG2 cells. We found that the decrease in AKAP350 
levels increases the G
0
/G
1
 population. We have previously 
demonstrated that the reduction in AKAP350 expression inhibits 
HepG2 cells differentiation,10 thus suggesting that the increase 
in 2N-containing cells was due to an increase in G
1
, and not 
in G
0
 cells. The entrance into the cell cycle, from G
0
 to G
1
, is 
accompanied by an increase in cyclin D1 levels. We found that 
cyclin D1 levels were increased in AKAP350KD cells, thus 
confirming that these cells entered the cell cycle, but could not 
progress to S phase.
Previous data indicated that disruption of centrosomes by 
decreasing different centrosomal proteins leads to G
1
 arrest in 
cells with wild-type p53.17 Our own experiments performed in 
HepG2 cells, which express functional p53,18 demonstrated that 
the increase in G
1
 events in AKAP350KD cells was accompanied 
by an activation of apoptosis, which is consistent with induction of 
G
1
 arrest. We investigated if the effect of AKAP350 knock down 
on the cell cycle was a general effect, due to a non-specific effect 
on centrosomal integrity, or if AKAP350 specifically participated 
in G
1
/S transition. We prepared HepG2 cell lines with stable 
centrosomal expression of an AKAP350 carboxyl-terminal 
domain, which induced a partial displacement of the endogenous 
protein. Instead of mimicking AKAP350 knock down effect, the 
expression of this fragment of the protein lead to an increase in 
cells with DNA content corresponding to S phase, accompanied 
by a rise in cyclin A levels. Therefore, AKAP350CTD expression 
Figure  3. effect of aKaP350cTD expression on the cell cycle in hepG2 cells. (A) GFP (control), aKaP350cTD1, and aKaP350cTD4 cells were fixed, 
marked with propidium iodide, and analyzed by flow cytometry. The figure shows typical outputs of control, aKaP350cTD1, and aKaP350cTD4 cells 
and the histogram representing the percentage of cells in the different phases of the cell cycle. (B) cyclin a expression was analyzed by immunoblot, 
using α-tubulin as loading control. The image is representative of three independent experiments. (C) aKaP350cTD1 and aKaP350cTD4 cells attached 
to microplates were cultured for 0, 24, 48, and 72 h. MTT assay was performed as described in Materials and Methods. Results are presented as the per-
centage of the absorbance of the cells cultured for 0 h. (D) control and aKaP350cTD cells were cultured for 72 h and stained with annexin V-FITc and 
propidium iodide (PI) and the percentages of apoptotic (annexin+) and dead (PI+) cells were determined by flow cytometry analysis. Bars represent the 
percentages of PI+ cells. Results are means ± s.e.m. of three independent experiments.*P < 0.01.
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was enough to induce the G
1
/S 
transition, revealing a specific role of 
AKAP350 in this process.
The Cdk2 recruitment to 
centrosomes is a critical event during 
G
1
/S transition.15 Previous studies 
demonstrate that expression of the 
AKAP450(2895–3908) domain 
increases the centrosomal levels 
of this mitotic kinase. Thus, we 
further evaluated if AKAP350CTD, 
equivalent to AKAP450(3643–
3908), participates in the 
centrosomal recruitment of Cdk2. 
AKAP350CTD expression induced 
an increase in Cdk2 protein levels 
at the centrosome. Although Cdk2 
activity is primarily modulated by 
its interaction with inhibitors, such 
as p21 or p17, or activators, such as 
cyclin E and cyclin A, other signaling 
proteins can further modulate this 
kinase. In fact, AKAP350 interacts 
with two proteins which can regulate the G
1
/S transition by 
modulating Cdk2 activity: calmodulin,11 which promotes this 
transition by activating cyclin E-Cdk2,19 and cyclin G
2
,20 which 
can induce G
1
 arrest by inhibiting Cdk2 activity.21 We speculated 
that, even though the centrosomal recruitment of Cdk2 by 
AKAP350 may be necessary to promote the G
1
/S transition, it 
might not be sufficient to ensure the increase of its centrosomal 
activity. Thus, we analyzed Cdk2 centrosomal activity in 
AKAP350CTD cells. NPM is a mainly nucleolar protein, whose 
centrosomal localization is cell cycle dependent. At late G
1
 phase, 
NPM is phosphorylated by cyclin E-Cdk2, phosphorylation 
which induces NPM release from the centrosomes and 
the initiation of centrosomal duplication.16 We found that 
AKAP350CTD expression induced an increase in Cdk2 specific 
phosphorylation of NPM, indicating that AKAP350 enables 
Cdk2 centrosomal activity at the G
1
/S transition.
Centrosomal duplication is initiated during late G
1
 phase by the 
disengagement of the two centrioles. We found that the initiation 
of centrosomal duplication was inhibited in AKAP350KD cells, 
and that AKAP350CTD, in spite of activating DNA synthesis, 
did not induce the initiation of centrosomal duplication. Thus, 
we were able to uncouple both events. We concluded that 
AKAP350 participation in centrosomal duplication does not 
depend exclusively on the regulation of Cdk2 activity at this 
organelle. In this regard, PKA participates in the separation 
of the centrioles by phosphorylating its structural component 
centrin.22 It is probable that AKAP350 integrates different events 
involved in the initiation of centrosomal duplication, such as 
phosphorylation of centrin by PKA, and phosphorylation of 
NPM by Cdk2. Further studies will be necessary to understand 
how these events are coordinated.
Summarizing, our results support a scenario where AKAP350 
participates in the G
1
/S transition by coordinating the activity 
of proteins involved in multiple events required for the initiation 
of both DNA synthesis and centrosomal duplication. On one 
hand, by means of its carboxyl-terminal domain, AKAP350 
enables Cdk2 activity at the centrosomes at this stage of the cell 
cycle, therefore stimulating the initiation of DNA synthesis. 
Although the facilitation of Cdk2 activity would also be involved 
in promoting centrosomal duplication, the recruitment of other 
signaling proteins by different AKAP350 domains are likewise 
necessary for this process to be initiated.
Materials and Methods
Cell culture
HepG2 cells (ATCC) were grown on plastic dishes in DMEN 
medium, as previously described.10
Reduction of AKAP350 expression by interfering RNA
In order to reduce AKAP350 expression, two specific 21 
nucleotide double chain RNA (siRNA), siRNA1 and siRNA2, 
and a scrambled control were designed as we previously 
described,10 and synthesized using an Ambion commercial 
kit “SilencerTMsiRNA”. HepG2 cells were transfected using 
Dharmafect 4 reagent (Thermo Fisher Scientific), as we 
previously described.10 Experiments were performed 48 h after 
transfection, and the specific decrease in AKAP350 expression 
was confirmed by immunoblotting.
Generation of stable cell lines (AKAP350CTD1 and 
AKAP350CTD4)
The AKAP350(3330–3595) domain, equivalent to 
AKAP450(3643–3908), was cloned into pEGFP-C2 (Clontech) 
generating a construct coding for GFP fused to the carboxyl-
terminal domain of AKAP350 (AKAP350CTD-GFP). We 
generated populations of HepG2 cells which stably express 
AKAP350CTD-GFP or GFP (control). HepG2 cells were 
Figure 4. aKaP350KD, aKaP350cTD, and control cells were fixed and stained with γ-tubulin and DaPI. 
centrosomes were identified as punctate structures enriched in γ-tubulin. Images were quantified by 
grouping cells as one-centrosome and two-centrosome cells. (A) The bars represent mean values of cells 
transfected with a control, or two different specific siRNas (aKaP350KD 1 and 2). (B) When analyzing 
aKaP350cTD cells, two-centrosome cells were further categorized in cells containing the centrosomes 
together (T) or separated (s), depending whether the distance between them was smaller or greater than 
2 µm, respectively. Results are means ± s.e.m. of three independent experiments. *P < 0.05.
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transfected by electroporation, as previously described.10 After 
24 h, the antibiotic Geneticin (Invitrogen, 500 μg/ml) was 
added to the media in order to select the transfected cells. For 
the maintenance of these cell lines, they were grown in a medium 
containing Geneticin 200 μg/ml in conditions otherwise similar 
to parental cells.
Cell viability and proliferation studies
Metabolic activity assessment (MTT assay)
Cells were cultured in 96-well microplates and 
methylthiazolyldiphenyl-tetrazolium bromide (MTT, Sigma-
Aldrich) was added into the culture medium at different time 
points, as we previously described.23 After 2 h, cells were lysed by 
addition of DMSO and absorbance of the metabolite produced 
from viable cells was detected at 540 nm in a microplate reader 
(Beckman Coulter LD400). Results were expressed as percentage 
of absorbance in control cells.
Annexin V/propidium iodide assay
Cells were detached from the petri dishes, gently 
homogenized in the culture medium/PBS and harvest. Apoptotic 
externalization of phosphatidylserine and cell death was assessed 
by staining with Annexin V-FITC and propidium iodide (Sigma 
Aldrich) or with Annexin V-PE and 7-Animo-Actinomycin (BD 
Biosciences), for cells expressing GFP associated fluorescence, 
coupled to flow cytometric analysis (Cell Sorter BD FACSAria 
II, BD Biosciences), following the manufacturers’s instructions.
Cell cycle analysis by flow cytometry
Cell distribution in the cell cycle was analyzed by determining 
the cellular DNA content by flow cytometry. 1 × 106 cells were 
fixed with cold 70% ethanol and then washed with PBS and 
marked with 50 μg/ml propidium iodide in a buffer containing 
0.1% sodium citrate, 0.02 mg/ml RNA, and 0.3% NP-40. 
Results were analyzed using WinMDi and CellCycle programs.
Immunoblotting
Cells were washed with cold phosphate buffered saline (PBS), 
scraped and pelleted at 200 g, for 5 min at 4 °C. Pelleted HepG2 
cells were resuspended in Triton X-100 1%/PBS pH 7.4 with 
protease and phosphatase inhibitors and subjected to two freeze-
thaw cycles. Lysates were centrifuged at 1000 g for 5 min and the 
clear supernatants were conserved. Total protein concentrations 
were measured according to Lowry et al.24 Solubilized membranes 
were heated 10 min at 70 °C in sample buffer (20 mM Tris, pH 
8,5, 1% SDS, 400 µM DTT, 10% glycerol). Samples containing 
equal amounts of proteins were subjected to SDS 4%/10% 
discontinuous or 12% PAGE. The proteins in the 4% gel were 
transferred to nitrocellulose membranes (Amersham Pharmacia), 
while 12% gel proteins were transferred to polyvinyl difluoride 
Figure 5. effect of aKaP350cTD expression on centrosomal levels of cdk2. (A) aKaP350cTD and control cells were cultured for 24 h and fixed with 
methanol. Fixed cells were double-stained for cdk2 and γ-tubulin, and analyzed by confocal microscopy. The first and second column show images of 
the channels corresponding to γ-tubulin and cdk2, and the third column the overlay view in RGB mode of the channels corresponding to GFP expres-
sion (green) and γ-tubulin (blue) and cdk2 (red) staining. Bar, 10 μm. arrows indicate centrosomes with orthogonal views. (B) centrosomal enriched 
fractions (cF) were prepared as described in Materials and Methods, and cdk2 levels at cF and at the starting material (sM) analyzed by western blot. 
γ-tubulin was used as loading control. Bars show the percentage of cdk2 recovered at cF. Results are mean ± s.e.m of 4 independent experiments. 
*P < 0.05.
Figure 6. effect of aKaP350cTD expression on centrosomal activity of 
cdk2. NPM and NPM(T199P) (PNPM) levels were analyzed by inmunob-
lotting in control and aKaP350cTD cells. Bars represent the ratio of the 
density of the PNPM band, divided by that corresponding to total NPM 
expression. Results are mean ± s.e.m of three independent experiments. 
*P < 0.05.
©
20
13
 L
an
de
s 
B
io
sc
ie
nc
e.
 D
o 
no
t d
is
tri
bu
te
.
www.landesbioscience.com cellular Logistics e26331-7
References
1. Schmidt PH, Dransfield DT, Claudio JO, Hawley 
RG, Trotter KW, Milgram SL, Goldenring JR. 
AKAP350, a multiply spliced protein kinase 
A-anchoring protein associated with centrosomes. 
J Biol Chem 1999; 274:3055-66; PMID:9915845; 
http://dx.doi.org/10.1074/jbc.274.5.3055
2. Takahashi M, Shibata H, Shimakawa M, Miyamoto 
M, Mukai H, Ono Y. Characterization of a novel 
giant scaffolding protein, CG-NAP, that anchors 
multiple signaling enzymes to centrosome and the 
golgi apparatus. J Biol Chem 1999; 274:17267-
74; PMID:10358086; http://dx.doi.org/10.1074/
jbc.274.24.17267
3. Witczak O, Skålhegg BS, Keryer G, Bornens 
M, Taskén K, Jahnsen T, Orstavik S. Cloning 
and characterization of a cDNA encoding 
an A-kinase anchoring protein located in the 
centrosome, AKAP450. EMBO J 1999; 18:1858-
68; PMID:10202149; http://dx.doi.org/10.1093/
emboj/18.7.1858
4. Sumiyoshi E, Sugimoto A. Cell polarity: centrosomes 
release signals for polarization. Curr Biol 2012; 
22:R281-3; PMID:22537634; http://dx.doi.
org/10.1016/j.cub.2012.03.009
5. Doxsey S. Re-evaluating centrosome function. Nat 
Rev Mol Cell Biol 2001; 2:688-98; PMID:11533726; 
http://dx.doi.org/10.1038/35089575
6. Nishimura T, Takahashi M, Kim HS, Mukai 
H, Ono Y. Centrosome-targeting region of 
CG-NAP causes centrosome amplification by 
recruiting cyclin E-cdk2 complex. Genes Cells 
2005; 10:75-86; PMID:15670215; http://dx.doi.
org/10.1111/j.1365-2443.2005.00816.x
7. Keryer G, Di Fiore B, Celati C, Lechtreck KF, 
Mogensen M, Delouvee A, Lavia P, Bornens M, 
Tassin AM. Part of Ran is associated with AKAP450 
at the centrosome: involvement in microtubule-
organizing activity. Mol Biol Cell 2003; 14:4260-71; 
PMID:14517334; http://dx.doi.org/10.1091/mbc.
E02-11-0773
membranes (Perkin Elmer Life Sciences). Blots were blocked 
with 5% non-fat milk in PBS/0.3% Tween 20. Nitrocellulose 
membranes were probed with the monoclonal mouse antibody 
anti-AKAP350 (14G2) (1:500)1 and polyvinyldifluoride 
membranes were probed with primary rabbit antibodies: anti-
NPM (1:1000, Cell Signaling), anti-Phospho-NPM (1:1000, 
Cell Signaling), anti-Cdk2 (1:1000, Santa Cruz Biotechnology), 
goat anti-cyclin A (1:500, Santa Cruz Biotechnology), or mouse 
anti-β-actin (1:2000, Sigma-Aldrich), anti-α-tubulin (1:2000, 
Sigma-Aldrich), and anti-Cyclin D1 (1:400, Santa Cruz 
Biotechnology). The blots were washed and incubated with the 
corresponding horseradish peroxidase-conjugated secondary 
antibodies. Bands were detected by chemiluminescence reaction 
(Amersham Pharmacia), after exposition to Kodak XAR film. 
Bands were quantified using the Image J program. In preparing 
the figures, brightness and contrast were adjusted in order to 
improve visualization.
Immunofluorescence and confocal microscopy
The cells were grown on glass coverslips and, at the end 
of each experiment, washed with PBS and fixed with 4% 
paraformaldehyde or in 100% methanol. Fixed cells were 
permeabilized and blocked with 0.3% Triton X-100/bovine 
serum albumin 1%/PBS, pH 7.4 for 10 min. For Cdk2 detection, 
cells were processed as previously described.6 Then they were 
incubated with rabbit anti-Cdk2 (1:100) and mouse anti-γ 
tubulin (1:500) or anti-AKAP350 (1:80) antibodies for 2 h at 
room temperature. The coverslips were washed, incubated with 
the secondary Alexa 555 and Cy5 conjugated antibodies and 
with 4′,6-diamidino-2-phenylindole (DAPI) and mounted with 
ProLong, as previously described.10 Fluorescence localization 
was detected by confocal laser microscopy (Nikon C1SiR with 
inverted microscope Nikon TE200). Serial optical 0.3 μm 
thick sections were collected in the z-axis. Z-stacks were built, 
and projections were obtained using Image J tools. In preparing 
the figures, adjustment in brightness and contrast were equally 
applied to the entire images using Adobe Photoshop software, in 
order to improve visualization of fluorescence.
Morphometric analysis of centrosomes
A morphometric analysis was performed on the images 
obtained by confocal microscopy in order to determine 
centrosome number and localization. γ-tubulin staining was 
used to identify centrosomes. Images were quantified by 
grouping cells in the following categories: one-centrosome cells 
and two-centrosome cells, considering the centrosomes attached 
or separated, depending on whether the distance between 
centrosomeswas smaller/equal or greater than 2 µm. At least 150 
cells were analyzed in each group.
Analysis of protein localization in centrosomes
Centrosomal localization of AKAP350 by confocal 
microscopy was performed as we have previously described.10 
As regards Cdk2, due to the extraction step performed prior 
to fixation and to its predominant nuclear localization, we 
found this method inappropriate to estimate its centrosomal 
localization. Alternatively, we prepared centrosome-enriched 
fractions by centrifugation in a discontinue sucrose gradient, 
using a method based on Moudju and Bornens,25 modified to 
improve centrosomal proteins resolution.26 Cells were gently 
sonicated in cold buffer containing 80 mM HEPES (pH 6.8), 
100 mM KCl, 14% sucrose, 1 mM MgCl
2
, 1 mM EGTA, and 
protease inhibitors. In order to eliminate unbroken cells and 
nuclear fractions, cell extracts were centrifuged at 1500 g for 15 
min. The supernatant was brought to 20% sucrose, 0.1% Triton 
X-100, and loaded on the top of a sucrose step gradient consisting 
of 70% and 40% steps. Samples were centrifuged at 100 000 g 
for 20 min and 6 fractions corresponding to the 40–70% sucrose 
fractions were collected. The best enrichment in centrosomes, 
assessed by γ-tubulin distribution, was obtained at the fraction 
corresponding to the 40–70% interface, and the 70% step 
bottom fraction.
Statistical analysis
Data are expressed as mean ± s.e.m. A paired Student t test was 
used for comparison between groups and non-parametric Mann–
Whitney test was used for comparisons within each experiment. 
P < 0.05 was considered statistically significant.
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